Cannabis PharmaDrug’s Sairiyo Therapeutics Offers Strategic Solutions for Advancing PD-001 (Patented Reformulated Cepharanthine) in Treatment of Viral Infectious DiseasesBy Alexander LeeAugust 28, 20240 On August 28, 2024, PharmaDrug Inc., a specialty pharmaceutical company focused on the research, development, and commercialization of controlled substances…
Cannabis PharmaDrug’s Sairiyo Therapeutics Obtains Approval to Begin Phase 1 Clinical Trial of Patented Reformulated CepharanthineBy Alexander LeeAugust 19, 20240 On August 19, 2024, PharmaDrug Inc. announced that its subsidiary, Sairiyo Therapeutics Inc., has received approval from the Australian Human…
